HBX Group International Statistics
Total Valuation
BME:HBX has a market cap or net worth of EUR 1.56 billion. The enterprise value is 1.97 billion.
| Market Cap | 1.56B |
| Enterprise Value | 1.97B |
Important Dates
The last earnings date was Wednesday, November 26, 2025.
| Earnings Date | Nov 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:HBX has 247.24 million shares outstanding. The number of shares has increased by 81.97% in one year.
| Current Share Class | 247.24M |
| Shares Outstanding | 247.24M |
| Shares Change (YoY) | +81.97% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 41.87% |
| Float | 217.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.02 |
| PS Ratio | 2.17 |
| PB Ratio | 1.98 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.54 |
| P/OCF Ratio | 8.40 |
| PEG Ratio | 0.55 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.14, with an EV/FCF ratio of 10.75.
| EV / Earnings | -28.52 |
| EV / Sales | 2.73 |
| EV / EBITDA | 5.14 |
| EV / EBIT | 6.09 |
| EV / FCF | 10.75 |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 1.55.
| Current Ratio | 0.96 |
| Quick Ratio | 0.91 |
| Debt / Equity | 1.55 |
| Debt / EBITDA | 3.18 |
| Debt / FCF | 6.69 |
| Interest Coverage | 1.77 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 5.80% |
| Return on Invested Capital (ROIC) | 10.26% |
| Return on Capital Employed (ROCE) | 15.80% |
| Revenue Per Employee | 203,160 |
| Profits Per Employee | -19,470 |
| Employee Count | 3,544 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:HBX has paid 17.00 million in taxes.
| Income Tax | 17.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 6.82 |
| 200-Day Moving Average | 8.80 |
| Relative Strength Index (RSI) | 46.50 |
| Average Volume (20 Days) | 359,725 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:HBX had revenue of EUR 720.00 million and -69.00 million in losses. Loss per share was -0.31.
| Revenue | 720.00M |
| Gross Profit | 634.00M |
| Operating Income | 325.00M |
| Pretax Income | -53.00M |
| Net Income | -69.00M |
| EBITDA | 385.00M |
| EBIT | 325.00M |
| Loss Per Share | -0.31 |
Balance Sheet
The company has 820.00 million in cash and 1.22 billion in debt, giving a net cash position of -404.00 million or -1.63 per share.
| Cash & Cash Equivalents | 820.00M |
| Total Debt | 1.22B |
| Net Cash | -404.00M |
| Net Cash Per Share | -1.63 |
| Equity (Book Value) | 791.00M |
| Book Value Per Share | 3.20 |
| Working Capital | -60.00M |
Cash Flow
In the last 12 months, operating cash flow was 186.00 million and capital expenditures -3.00 million, giving a free cash flow of 183.00 million.
| Operating Cash Flow | 186.00M |
| Capital Expenditures | -3.00M |
| Free Cash Flow | 183.00M |
| FCF Per Share | 0.74 |
Margins
Gross margin is 88.06%, with operating and profit margins of 45.14% and -9.58%.
| Gross Margin | 88.06% |
| Operating Margin | 45.14% |
| Pretax Margin | -7.36% |
| Profit Margin | -9.58% |
| EBITDA Margin | 53.47% |
| EBIT Margin | 45.14% |
| FCF Margin | 25.42% |
Dividends & Yields
BME:HBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -81.97% |
| Shareholder Yield | -81.97% |
| Earnings Yield | -4.42% |
| FCF Yield | 11.71% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:HBX has an Altman Z-Score of 0.62 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.62 |
| Piotroski F-Score | 4 |